"Lymphocyte Transfusion" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The transfer of lymphocytes from a donor to a recipient or reinfusion to the donor.
Concept/Terms
Lymphocyte Transfusion- Lymphocyte Transfusion
- Lymphocyte Transfusions
- Transfusion, Lymphocyte
- Transfusions, Lymphocyte
Below are MeSH descriptors whose meaning is more general than "Lymphocyte Transfusion".
Below are MeSH descriptors whose meaning is more specific than "Lymphocyte Transfusion".
This graph shows the total number of publications written about "Lymphocyte Transfusion" by people in Harvard Catalyst Profiles by year, and whether "Lymphocyte Transfusion" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 2 | 0 | 2 |
| 1994 | 4 | 0 | 4 |
| 1995 | 3 | 0 | 3 |
| 1996 | 1 | 2 | 3 |
| 1997 | 2 | 3 | 5 |
| 1998 | 3 | 1 | 4 |
| 1999 | 3 | 1 | 4 |
| 2000 | 3 | 2 | 5 |
| 2001 | 5 | 1 | 6 |
| 2002 | 3 | 4 | 7 |
| 2003 | 5 | 2 | 7 |
| 2004 | 2 | 3 | 5 |
| 2005 | 1 | 2 | 3 |
| 2006 | 2 | 1 | 3 |
| 2008 | 4 | 3 | 7 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 3 | 4 |
| 2011 | 1 | 2 | 3 |
| 2012 | 2 | 1 | 3 |
| 2013 | 1 | 0 | 1 |
| 2014 | 3 | 0 | 3 |
| 2015 | 2 | 0 | 2 |
| 2016 | 3 | 1 | 4 |
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 2 | 1 | 3 |
Below are the most recent publications written about "Lymphocyte Transfusion" by people in Profiles.
-
Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy. Cell Rep. 2021 11 09; 37(6):109992.
-
CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication. J Clin Invest. 2021 04 01; 131(7).
-
T-cell-based Immunotherapies for Haematological Cancers, Part B: A SWOT Analysis of Adoptive Cell Therapies. Anticancer Res. 2021 Mar; 41(3):1143-1156.
-
The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era. Biol Blood Marrow Transplant. 2020 06; 26(6):1137-1143.
-
Key Aspects of the Immunobiology of Haploidentical Hematopoietic Cell Transplantation. Front Immunol. 2020; 11:191.
-
Infusion of Alloanergized Donor Lymphocytes after CD34-selected Haploidentical Myeloablative Hematopoietic Stem Cell Transplantation. Clin Cancer Res. 2018 09 01; 24(17):4098-4109.
-
Donor-lymphocyte infusion following haploidentical hematopoietic cell transplantation with peripheral blood stem cell grafts and PTCy. Bone Marrow Transplant. 2017 Dec; 52(12):1623-1628.
-
Acute graft-versus-host disease is regulated by an IL-17-sensitive microbiome. Blood. 2017 04 13; 129(15):2172-2185.
-
Donor Lymphocyte Infusion-Mediated Graft-versus-Host Responses in a Preclinical Swine Model of Haploidentical Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2016 11; 22(11):1953-1960.
-
Improved Outcome of Refractory/Relapsed Acute Myeloid Leukemia after Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation with Myeloablative Conditioning and Early Prophylactic Granulocyte Colony-Stimulating Factor-Mobilized Donor Lymphocyte Infusions. Biol Blood Marrow Transplant. 2016 10; 22(10):1867-1873.